Publications by authors named "Priyanka Ashwath"

Tuberculosis is the leading cause of mortality by infectious agents worldwide. The necrotic debris, known as caseum, which accumulates in the center of pulmonary lesions and cavities is home to nonreplicating drug-tolerant that presents a significant hurdle to achieving a fast and durable cure. Fluoroquinolones such as moxifloxacin are highly effective at killing this nonreplicating persistent bacterial population and boosting TB lesion sterilization.

View Article and Find Full Text PDF

Multi-drug efflux is one of the resistant determinants in Klebsiella pneumoniae that are encountered in a broad range of clinically relevant antimicrobial agents. An alternative method to strategically induce sensitivity in drug-resistant K. pneumoniae and improve the efficacy of the existing antibiotics is the need of the hour.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic bacteria pose a major threat to human health but also offer potential therapeutic opportunities for disease prevention and treatment.
  • The article discusses virulence determinants, which are elements that help pathogens cause damage to their hosts, and how targeted therapies can be developed to combat these mechanisms.
  • It highlights the innovative use of CRISPR-based therapy and antisense RNA (asRNA) as new strategies for selectively disabling the virulence factors in these bacteria, marking the first review to combine both technologies in this context.
View Article and Find Full Text PDF

Biofilms reduce the bacterial growth rate, inhibit antibiotic penetration, lead to the development of persister cells and facilitate genetic exchange. The biofilm-associated Klebsiella pneumoniae infections have not been well studied, and their implications in overcoming the effects of antimicrobial therapy are yet to be fully understood. Hence this study evaluated the antibiotic resistance pattern, antibiotic resistance determinants of extended-spectrum beta-lactamase (ESBL) family.

View Article and Find Full Text PDF

The increasing resistance of the disease-causing pathogens to antimicrobial drugs is a public health concern and a socio-economic burden. The emergence of multi-drug resistant strains has made it harder to treat and combat infectious diseases with available conventional antibiotics. There are currently few effective therapeutic regimens for the successful prevention of infections caused by drug-resistant microbes.

View Article and Find Full Text PDF